Aktionärsstruktur

Inhaber in %
Freefloat 99,02
Government Pension Fund - Global (The) 2,63
Vanguard Total International Stock Index Fund 1,73
Roche Holding AG 0,97
PRIMECAP Management Co. 0,79
Alecta Pension 0,74
CSIF (CH) Umbrella - Switzerland Total Market Index Blue 0,72
Dodge & Cox Funds - International Stock Fund 0,66
Vanguard Developed Markets Index Fund 0,64

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 91.747 94.052 93.734 94.442 97.735
Umsatz pro Mitarbeiter in Mio. EUR 0,52 0,54 0,57 0,60 0,63

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 28.182 28.670 31.572 32.244 31.254
Summe Anlagevermögen 44.230 46.266 45.401 46.392 48.329
Summe Aktiva 75.763 76.819 76.676 78.517 83.091

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 23.251 22.355 18.960 18.770 15.582
Summe Fremdkapital 52.463 50.417 47.669 48.151 47.224
Summe Eigenkapital 23.300 26.402 29.007 30.366 35.867
Summe Passiva 75.763 76.819 76.676 78.517 83.091

Adresse

Grenzacherstrasse 124, 4070 Basel
Telefon +41 (61) 688-11-11
Fax +41 (61) 691-93-91
Internet http://www.roche.com

Management

Alan Hippe
Chief Financial & Information Technology Officer
André S. Hoffmann
Vice Chairman
Anita Hauser
Director
Bernard J. Poussot
Non-Executive Director
Christoph Franz
Chairman
Claudia Süssmuth Dyckerhoff
Director
Cristina A. Wilbur
Head-Group Human Resources
Gallia Levy
Associate Group Medical Director-Hematology
Gottlieb A. Keller
Secretary & General Counsel
Hans Clevers
Director
Jason S. Ehrlich
Senior Group Medical Director
Jorg Duschmale
Director
Julie Brown
Director
Karl Mahler
Head-Investor Relations
Karsten Jung
Global Product Strategy Head
Michael D. Varney
Head-Genentech Research & Early Development
Pablo Umaña
Head-Cancer Immunotherapy Discovery
Patrick Frost
Director
Paul Bulcke
Non-Executive Director
Per-Olof Attinger
Secretary-Executive Committee & Head-CEO Office
Richard P. Lifton
Non-Executive Director
Severin Schwan
Chief Executive Officer & Executive Director
Urs Jaisli
Chief Compliance Officer
William Pao
Head-Pharma Research & Early Development